Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
NeoImmuneTech
BioNTech SE
Eisai Inc.
Sichuan Enray Pharmaceutical Sciences Company
Lokon Pharma AB
A2 Biotherapeutics Inc.
Essen Biotech
Essen Biotech
Nouscom SRL
St. Jude Children's Research Hospital
DualityBio Inc.
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Eli Lilly and Company
GV20 Therapeutics
Eli Lilly and Company
Mirati Therapeutics Inc.
Genfleet Therapeutics (Shanghai) Inc.
National University Hospital, Singapore
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
NuCana plc
Yonsei University
Turning Point Therapeutics, Inc.
PharmaMar
Marengo Therapeutics, Inc.
Cancer Research UK
Cancer Research UK
Hoffmann-La Roche
Numab Therapeutics AG
Thomas Jefferson University
Thomas Jefferson University
AtlasMedx, Incorporated
A2 Biotherapeutics Inc.
Xynomic Pharmaceuticals, Inc.
iOnctura
Intensity Therapeutics, Inc.
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Mansoura University
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
Salubris Biotherapeutics Inc
ENB Therapeutics, Inc
Cantargia AB
Cancer Research UK
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.